Aripiprazole-Associated Rhabdomyolysis in a 17-Year-Old Male
[ X ]
Tarih
2023
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Acad Medical Sciences I R Iran
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Rhabdomyolysis is a rare serious side effect of antipsychotic medication use. There are cases of rhabdomyolysis due to the use of clozapine, risperidone, olanzapine, and haloperidol in the literature. In this report, we describe a rhabdomyolysis case developed on the 13th day of using 2.5 mg /day aripiprazole in a 17-year-old male patient with a diagnosis of somatic symptom disorder. This case is one of the youngest in the literature to develop rhabdomyolysis after the use of aripiprazole. Moreover, this case is distinguished from the others with its low-dose, short-term and single antipsychotic use. In the child and adolescent age group, routine blood tests should be done before starting medication. Symptoms that appear to be nonspecific and that may be overlooked or may be thought to be caused by an existing psychiatric complaint should be carefully and thoroughly considered during follow-up.
Açıklama
Anahtar Kelimeler
Aripiprazole; Atypical antipsychotics; Case report; Rhabdomyolysis
Kaynak
Archives of Iranian Medicine
WoS Q Değeri
Q3
Scopus Q Değeri
Q1
Cilt
26
Sayı
1
